Keyphrases
Absence of Evidence
16%
Adverse Events
16%
Antibiotic Therapy
100%
Antibiotic Treatment
50%
Azithromycin
16%
Aztreonam
33%
Bacterial Density
16%
Bronchospasm
16%
Ciprofloxacin
16%
Clinical Improvement
16%
Conflicting Results
16%
Erythromycin
16%
Evidence-based Treatment
16%
Exacerbation Rate
50%
Forced Expiratory Volume in 1 Second (FEV1)
50%
Gentamycin
16%
Inclusion Criteria
16%
Inhaled Colistin
16%
Lung Function
50%
Meta-analysis
16%
Pseudomonas Aeruginosa (P. aeruginosa)
66%
Quality of Life
100%
Quality of Life Improvement
16%
Reporting Item
16%
Sputum
16%
Sputum Culture
50%
Sputum Production
16%
Systematic Meta-analysis
16%
Tobramycin
16%
Treatment Algorithm
16%
Treatment Regimen
16%
Medicine and Dentistry
Adverse Event
14%
Antibiotic Therapy
100%
Azithromycin
14%
Aztreonam
28%
Bronchiectasis
100%
Ciprofloxacin
14%
Colistimethate
14%
Cystic Fibrosis
100%
Erythromycin
14%
Forced Expiratory Volume
14%
Gentamicin
14%
Lung
42%
Meta-Analysis
14%
Pseudomonas aeruginosa
57%
Quality of Life
100%
Sputum
28%
Sputum Culture
42%
Systematic Review
100%
Tobramycin
28%